TNF and Alzheimer disease: Systemic inflammation leading to increased TNFα is associated with disease progression/cognitive decline in AD patients [2], and systemic challenge, such as administration of lipopolysaccharide (LPS), can provoke waves of TNFα expression in the rodent brain [3].